ArticlePoultry science2026
N-acetylated chito-oligosaccharides and xylanase improve intestinal health and production performance in laying hens.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synergistic feed additives that target the gut-immune axis offer a promising strategy to enhance health, nutrient utilization, and productivity. N-acetylated chito-oligosaccharides (NACOS) provide stimbiotic, antimicrobial, and immunomodulatory benefits, while xylanase improves non-starch polysaccharide degradation, nutrient availability, and microbial fermentation. This study evaluated a novel dual-action strategy combining NACOS, xylanase, or their combination (CXNRGY) on production performance, nutrient utilization, jejunal histomorphology, systemic immune status, and the cecal microbial community in laying hens. Forty HiSex White laying hens were randomly assigned to four dietary groups and fed either a control diet (CD) or the CD supplemented with NACOS (50 g/t), Xylanase (45,000 U/kg), or CXNRGY at the same respective doses. Dietary supplementation improved production metrics: egg weight was highest in the CXNRGY group compared with control and NACOS (P < 0.001), while egg mass increased in Xylanase, NACOS and CXNRGY groups compared to control in the second phase (P < 0.001). Xylanase and CXNRGY achieved the lowest FCR compared with NACOS and the control group. Haugh unit and albumen height were elevated in NACOS and Xylanase treatments (P < 0.05), whereas CXNRGY maximized shell thickness and breaking strength (P < 0.001). Nutrient utilization of crude fat, organic matter, and apparent metabolizable energy (AME) was significantly improved by NACOS, while Xylanase and CXNRGY further enhanced fiber and protein utilization. NACOS produced the greatest improvements in jejunal morphology (P < 0.05) and, along with Xylanase and CXNRGY, reduced serum IL-1α, TNF-α, and IL-10 (P < 0.05), while IL-1β and IL-6 were unaffected (P > 0.05). Notably, CXNRGY altered the cecal microbiota by increasing the relative abundance of Lachnospiraceae, Ruminococcaceae, Subdoligranulum, Prevotellaceae and Clostridia, while decreasing Bacteroidaceae and Negativicutes, indicating a synergistic effect on microbial community structure. Xylanase enhances nutrient utilization and prebiotic availability, while NACOS strengthens gut barrier integrity and modulates immune responses. These results indicate that combining NACOS with xylanase provides a synergistic, antibiotic-free nutritional strategy that enhances gut health, immunity, egg quality, and overall performance in laying hens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.